# Accelerate the next wave of antibody and protein innovation Design and develop next-generation biologics with the ability to adapt and scale. ## Next generation antibodies demand a modern digital solution Antibodies are turning the tide in the fight against critical diseases in oncology and immunology. Innovations in monoclonal antibody technology, bispecifics, and antibody-drug conjugates continue to push the envelope of efficacy and safety. Antibody R&D teams are investigating a variety of antibody formats, modernizing scientific workflows with NGS and CRISPR, and automating key workflows to bring the next wave of breakthrough antibodies to the market. The industry requires a new kind of digital solution that is immediately ready to handle the complexity of modern antibody R&D. It must provide adaptability to keep up with the frequent evolutions within the industry, and traceability to give R&D teams a complete view of their programs and candidates. ## Antibody and Protein R&D Solutions - Benefits - Capabilities - Accelerators - Services Hundreds of biopharma innovators trust Benchling’s Antibody and Protein Solutions to advance their biologics through the R&D lifecycle. Work across a broad range of antibody and protein discovery modalities (e.g. phage display, hybridoma, B-cell) with fit-for-purpose software designed for speed, collaboration, and insights. Get the best from in silico molecular biology tools, ELN, LIMS, and LES in one modern, digital platform designed for biologics R&D. [Download the data sheet](https://www.benchling.com/resources/benchling-enables-end-to-end-antibody-research-and-drug-discovery-platforms) ### Streamline collaboration across R&D teams Teams work faster and more efficiently together using structured workflows, templates, sample transfers, and data sharing. Connect key phases of the antibody R&D process, including target identification, hit selection, sequencing, plasmid design, protein production, and in vitro / in vivo analysis. ### Gain insights and traceability across the entire antibody R&D process Manage all sequences, samples, and results in a centralized and secure cloud platform. Scientists can find the data they need quickly using advanced search capabilities, with full traceability down to the sequence level. Select pre-built dashboards or customize your own to get insights that improve operational performance. Run antibody screening campaigns Screen antibodies generated from hybridomas and primary B-cell cultures as well as arrayed libraries from phage and yeast display technologies. Create standardized experimental plans and study protocols using established Notebook templates. Use Inventory to track supply of B-cells, hybridomas, and other key biological entities. Perform sequencing and plasmid design Visualize plasmid maps with intuitive layouts and helpful feature highlighting tools. Analyze DNA and amino acid sequences and share feature libraries with teammates. Perform high-throughput combinatorial cloning to design your plasmids efficiently. Coordinate protein expression and purification runs Set up protein expression runs quickly using standardized templates. Confirm sequence or sample identity and history with full end-to-end lineage tracking. Analyze and optimize expression parameters with in-platform data visualization. Characterize in vitro antibody properties Relay sample information and related results accurately and efficiently between teams. Execute analytical assays quickly and enforce SOPs with protocols and templates. Integrate directly with analytical instruments to centralize all assay results for easy analysis and visualization. Study pharmacology, safety, and efficacy in vivo Plan in vivo studies and generate study protocols with collaborative tools. Use Studies to monitor vivarium animals, perform randomization, and collect in-life study measurements and calculations. Automatically link bioanalytical assay results to tissue samples with a unified data model. The Antibody and Protein Therapy R&D Accelerators provide best practices that shorten time-to-value for research and process development. The Accelerators contain: - **Data model**– entity relationship diagram (ERD) which serves as an implementation blueprint - **Tenant configuration** – pre-defined tenant configuration using templates and dashboards for registering entities, tracking results, increasing inventory utilization, and streamlining workflows - **Solution Guide** – highlight capabilities and latest product features Benchling’s services support customers from implementation through ongoing success. - [Professional Services](https://www.benchling.com/services) – solution-specific domain expertise to jumpstart your optimal implementation - [Customer Success](https://www.benchling.com/customer-success) – continual solution optimization that takes advantage of new feature releases and ongoing industry learning ## How we deliver ### Dedicated expertise Our Customer Experience professionals possess deep scientific expertise, as well as training on information technology best practices. They apply this know-how to support antibody customers across a wide range of R&D teams. ### Continuous oversight Leverage Benchling's pre-implementation solutions consulting, professional implementation services, and customer success management expertise to help you get the most out of Benchling. ### Focused R&D support Take advantage of Benchling’s foundational implementation guides, developed by our Customer Experience team to support many antibody R&D functions. ## See Benchling's Antibody and Protein R&D Solution in action - Xilio Therapeutics Click for sound “Benchling offers a very simple way of naming molecules and storing the sequences... it's [now] in a format where we can learn more complex lessons from our historical data. In that sense, managing data in a more structured, formatted way is very powerful.” Dheeraj Tomar Scientist, Structural Biology [Read the full customer story](https://www.benchling.com/resources/benchling-helps-xilio-therapeutics-see-complex-lessons-in-data-copy) ## Learn more about antibody and protein R&D \ \ Data sheet\ \ **Benchling enables end-to-end antibody research and drug discovery platforms**](https://www.benchling.com/resources/benchling-enables-end-to-end-antibody-research-and-drug-discovery-platforms) \ \ Video\ \ **Benchling for Antibody Discovery**](https://www.benchling.com/resources/benchling-for-antibody-discovery) \ \ On-demand webinar\ \ **The future of antibody drug discovery: From target validation to candidate selection**](https://www.benchling.com/webinars/the-future-of-antibody-drug-discovery-from-target-validation-to-candidate).